# This file is organized in a manner that allows the top-level sections to be broken into separate YAML files later.
# For example, `overview:` becomes `overview.yaml`, `DMS:` becomes `DMS.yaml`, etc.
overview:
  order: 1
  # viral family: one of ['coronaviridae', 'flaviviridae', 'picornaviridae', 'togaviridae']
  family: coronaviridae
  name: "SARS-CoV-2 / MERS-CoV Mpro protease"
  target: Mpro
  program_code: ASAPPTGTTM
  program_nickname: ASAP-COV-MPRO
  viruses:
    - MERS-CoV
    - SARS-CoV-2
  img: "SARS-CoV-2 Mpro.png"
targeting_opportunity:
  status: completed
  url: https://asapdiscovery.notion.site/Targeting-Opportunity-SARS-CoV-2-MERS-CoV-Mpro-warm-start-a8457fb68f794b398b5f902429917dd4
  events:
    - date: 2023-03-19
      description: Initial draft
DMS:
  # 'status' controls the status box rendered for this stage
  status: completed
  # 'dates' section: can (optionally) list 'started', 'completed', and 'updated'
  #   is used to determine whether to report these products in the RPPR or to highlight new data on the Pipeline diagram
  products:
  # This paper is citeable
  - name: Analysis of circulating variants of SARS-CoV-2 Mpro (nsp5)
    date-completed: 2023-01-31
    url: https://jbloomlab.github.io/SARS2-mut-fitness/nsp5.html
    preprint: https://www.biorxiv.org/content/10.1101/2023.01.30.526314v1
    RPPR: [P1]
    events:
      - date: 2023-01-31
        description: A preprint was posted to bioRxiv.
      - date: 2023-01-31
        description: A public website was posted.
    links:
      - action: Download simulation scripts
        short: GitHub
        description: Scripts for structure preparation, docking, and simulation of MEN1 mutants interacting with inhibitors
        url: https://github.com/choderalab/men1
      - action: Download the datasets
        short: OSF
        description: Data from free energy calculations, Folding@home trajectories, and Markov state models of MEN1 mutants
        url: https://osf.io/uge5j/
  # NOTE: This paper is not citeable by the RPPR, but we will be able to cite it if we reformat it as an interactive website
  - name: Deep mutational scanning of SARS-CoV-2 Mpro
    url: https://elifesciences.org/articles/77433    
    doi: 10.7554/eLife.77433
    RPPR: []
    events:
      - date: 2022-07-26
        description: Published in eLife.    
  
TPP:
  status: completed
  title: SARS-CoV-2 and MERS-CoV Mpro oral community use
  url: https://docs.google.com/presentation/d/1uZht18ZJnHuwMtwxY4prDBSl4SFMK-ics4ERhDgiJ2s/edit#slide=id.g208e3a5fffa_0_3
  anchor: ASAP-MERS-CoV-SARS-CoV-2-TPP
  events:
    - date: 2023-03-01
      description: Initial draft

TCP:
  status: completed
  url: https://docs.google.com/presentation/d/1uZht18ZJnHuwMtwxY4prDBSl4SFMK-ics4ERhDgiJ2s/edit#slide=id.g1ddbe4124e9_2_11
  anchor: ASAP-COV-MPRO-TCP
  title: MERS-CoV & SARS-CoV-2 Oral MPro inhibitor
  events:
    - date: 2023-03-01
      description: Initial draft  

assay_cascade:
  status: completed
  url: https://dndi.org/diseases/covid-19/target-product-profile/

TEP:
  status: completed
  url: https://dndi.org/diseases/covid-19/target-product-profile/

hit_to_lead:
  status: completed
  url: https://dndi.org/diseases/covid-19/target-product-profile/

lead_optimization:
  status: in-progress
  url: https://dndi.org/diseases/covid-19/target-product-profile/

preclinical:
  status: not-started
  url: https://dndi.org/diseases/covid-19/target-product-profile/

IND:
  status: not-started
  url: https://dndi.org/diseases/covid-19/target-product-profile/

clinical:
  status: not-started
  url: https://dndi.org/diseases/covid-19/target-product-profile/

NDA:
  status: not-started
  url: https://dndi.org/diseases/covid-19/target-product-profile/

